BLACK FRIDAY

ADVFN

Celebrando 25 años Est 1999-2024

Ahorra hasta 60%* en Forex

1 año 40%, 2 años 40% y *3 años 60%

*Durante 3 años $1.035.00 solo $414.00

ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,032.38
0.56%
Dow Jones
44,910.65
0.42%
US Dollar vs MXN
20.3755
0.00%
Brent Oil
71.98
-0.08%
Bitcoin
96,591.73
-0.92%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. BNP Paribas (BNP) Cotización

BNP Paribas

BNP Paribas (BNP)

Danone
Danone
Danone
Danone
BNP Paribas
56.64
0.50
(0.89%)
Cerrado 30 Noviembre 10:30AM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
56.64
Postura de Compra
56.60
Postura de Venta
56.95
Volume Operado de la Acción
3,399,190
55.55 Rango del Día 56.93
53.08 Rango de 52 semanas 73.08
Capitalización de Mercado [m]
69.872B
Precio Anterior
56.14
Precio de Apertura
55.60
Hora
618
@
56.64
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
2,685,869
Acciones en circulación
1,233,609,675
Rendimiento del Dividendo
8.12%
Ratio Precio/Utilidad
6.37
Beneficio por acción (BPA)
8.9
turnover
57.98B
Beneficio neto
10.98B

Acerca de BNP Paribas

Sector
Commercial Banks, Nec
Industria
Commercial Banks, Nec
Sitio web
group.bnpparibas
Sede
Paris, Paris, Fra
Fundado
-
BNP Paribas is listed in the Commercial Banks sector of the Euronext with ticker BNP. The last closing price for BNP Paribas was 56.14 €. Over the last year, BNP Paribas shares have traded in a share price range of 53.08 € to 73.08 €.

BNP Paribas currently has 1,233,609,675 shares in issue. The market capitalisation of BNP Paribas is 69.25 € billion. BNP Paribas has a price to earnings ratio (PE ratio) of 6.37.

BNP Últimas noticias

Más noticias

BNP PARIBAS SA: NOTIFICATION BY THE ACPR OF THE DESIGNATION OF BNP PARIBAS ON THE LIST OF G-SIBs

BNP PARIBAS SA: NOTIFICATION BY THE ACPR OF THE DESIGNATION OF BNP PARIBAS ON THE LIST OF G-SIBs   NOTIFICATION BY THE ACPR OF THE DESIGNATION OF BNP PARIBAS ON THE LIST OF G-SIBs Press...

27 Noviembre 2024
UK Regulatory

BNP PARIBAS SA : NOTIFICATION PAR L’ACPR DE L’APPARTENANCE DE BNP PARIBAS A LA LISTE DES ETABLISSEMENTS D’IMPORTANCE SYSTEMIQUE MONDIALE (« G-SIBs »)

BNP PARIBAS SA : NOTIFICATION PAR L’ACPR DE L’APPARTENANCE DE BNP PARIBAS A LA LISTE DES ETABLISSEMENTS D’IMPORTANCE SYSTEMIQUE MONDIALE (« G-SIBs »)   NOTIFICATION PAR L’ACPR DE L’APPARTENANCE DE...

27 Noviembre 2024
UK Regulatory

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - octobre 2024

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - octobre 2024 Raison sociale de l'émetteur : BNP PARIBAS - SA au capital de 2.261.621.342 euros Immatriculée sous le n° 662 042 449...

05 Noviembre 2024
UK Regulatory

GROUPE BNP PARIBAS : Communiqué de mise à disposition du 3ème amendement au Document d’enregistrement universel et rapport financier annuel 2023

GROUPE BNP PARIBAS : Communiqué de mise à disposition du 3ème amendement au Document d’enregistrement universel et rapport financier annuel 2023 Mise à disposition du 3ème amendement au Document...

31 Octubre 2024
UK Regulatory

GROUPE BNP PARIBAS : Release of the third amendment to the Universal registration document and annual financial report 2023

GROUPE BNP PARIBAS : Release of the third amendment to the Universal registration document and annual financial report 2023 Release of the third amendment to the Universal registration document...

31 Octubre 2024
UK Regulatory

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - septembre 2024

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - septembre 2024 Raison sociale de l'émetteur : BNP PARIBAS - SA au capital de 2.261.621.342 eurosImmatriculée sous le n° 662 042 449...

03 Octubre 2024
UK Regulatory

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - août 2024

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - août 2024 Raison sociale de l'émetteur : BNP PARIBAS - SA au capital de 2.261.621.342 euros Immatriculée sous le n° 662 042 449...

05 Septiembre 2024
UK Regulatory

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - juillet 2024

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - juillet 2024 Raison sociale de l'émetteur : BNP PARIBAS - SA au capital de 2.261.621.342 euros Immatriculée sous le n° 662 042 449...

05 Agosto 2024
UK Regulatory

GROUPE BNP PARIBAS : Mise à disposition du 2ème amendement au Document d’enregistrement universel et rapport financier annuel 2023

GROUPE BNP PARIBAS : Mise à disposition du 2ème amendement au Document d’enregistrement universel et rapport financier annuel 2023 Mise à disposition du 2ème amendement au Document...

02 Agosto 2024
UK Regulatory

GROUPE BNP PARIBAS : Release of the second amendment to the Universal registration document and annual financial report 2023

GROUPE BNP PARIBAS : Release of the second amendment to the Universal registration document and annual financial report 2023 Release of the second amendment to the Universal registration document...

02 Agosto 2024
UK Regulatory
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-1.96-3.3447098976158.658.7654.63406968556.46000436DE
4-5.93-9.4773853284362.5763.9854.63343473159.00434097DE
12-6.65-10.507189129463.2966.9954.63268586961.57850621DE
26-11.29-16.620050051567.9368.6654.63271477461.63160412DE
520.540.9625668449256.173.0853.08265576561.71902185DE
1560.540.9625668449256.173.0840.665313140956.53956182DE
2605.7411.277013752550.973.0824.505363605849.56966864DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MLCOTCoretech 5
0.0175 €
(75.00%)
11.13k
MLSRPSpeed Rabbit Pizza
6.30 €
(20.00%)
5
ALTDTonner Drones
0.0116 €
(18.37%)
45.26M
TRACTTeract SA
0.848 €
(18.11%)
123.46k
ALVALValbiotis SA
1.40 €
(18.04%)
613.41k
ALKALKALRAY SA
1.28 €
(-40.74%)
637.99k
ALNEVNeovacs
0.0002 €
(-33.33%)
16.21M
ALTAILighton
18.00 €
(-24.37%)
173.99k
MLLOILocasystem International
12.50 €
(-18.30%)
6
ALSAFSAFE
0.074 €
(-17.41%)
178.68k
ALTDTonner Drones
0.0116 €
(18.37%)
45.26M
BCPBanco Comercial Portugues SA
0.4478 €
(0.22%)
38.08M
ATOAtos SE
0.8972 €
(14.82%)
22.54M
ALHPIHopium SA
0.0089 €
(-2.20%)
19.27M
ALNEVNeovacs
0.0002 €
(-33.33%)
16.21M

Discusión

Ver feed completo
Walter4 Walter4 4 minutos hace
https://www.biospace.com/press-releases/biogene-therapeutics-welcomes-professor-mirela-delibegovic-frse-to-its-scientific-advisory-board
PRVCF
Wayne R Wayne R 7 minutos hace
I had a problem with my freezer many years ago, there wasn't a lot of stuff in there but I created meals with the stuff.

One thing was a bag of spinach. I decided to make lasagna using that, with a meat sauce of course, just another ingredient.

It turned out so good th
oilin07 oilin07 16 minutos hace
Has anyone reached out to the former fed reserve banker on our board?
BLLB
oilin07 oilin07 17 minutos hace
Who said hope is a strategy? Besides as a bag holder i would rather have hope than whine like you do.
BLLB
ksquared ksquared 17 minutos hace
Morning, Bull. Good to see you up and ready to rumble.
Enjoy your warm weather.
We're in the low 20s here.
Fine by me, but I feel for Gmenfan.
I have college football to keep me warm. (HAR!)
Have a good one.
eagle8 eagle8 21 minutos hace
Peter Davis
@peter_brit
#dcvax $nwbo #gbm

Linda Liau (co-authored) peer-reviewed 'Nature' article..

Integrated molecular and functional characterization of the intrinsic apoptotic machinery identifies therapeutic vulnerabilities in glioma
Elizabeth
NWBO
Seminole Red Seminole Red 27 minutos hace
thanks for posting Larry....RIP Wow Happens
jrockents jrockents 28 minutos hace
not turning to the darkside just yet!!!!! but my mans surfkast n techromancer are making some sense rite now!!!!!!!! this will be my first (hopefully last) bear post!!!! but its been a whole fffing year n still no had??? whaaat blagmans excuse time n time again was its the tv world everything takes
MWWC
jrockents jrockents 28 minutos hace
not turning to the darkside just yet!!!!! but my mans surfkast n techromancer are making some sense rite now!!!!!!!! this will be my first (hopefully last) bear post!!!! but its been a whole fffing year n still no had??? whaaat blagmans excuse time n time again was its the tv world everything takes
MWWC
chipboarder chipboarder 28 minutos hace
As Robert Frost wrote….”and miles to go before I sleep”.
LQMT
Canna_Business Canna_Business 29 minutos hace
Pathway to Medical Cannabis: Prohibition to Prescription

1. DEA removes cannabis from Schedule 1.
2. FDA studies cannabis for medical use.
3. Hospitals and pharmacies administer medical cannabis.
4. Insurance companies cover co-pays for patients.
5. L
XRPUSD
Canna_Business Canna_Business 29 minutos hace
Pathway to Medical Cannabis: Prohibition to Prescription

1. DEA removes cannabis from Schedule 1.
2. FDA studies cannabis for medical use.
3. Hospitals and pharmacies administer medical cannabis.
4. Insurance companies cover co-pays for patients.
5. L
Canna_Business Canna_Business 29 minutos hace
Pathway to Medical Cannabis: Prohibition to Prescription

1. DEA removes cannabis from Schedule 1.
2. FDA studies cannabis for medical use.
3. Hospitals and pharmacies administer medical cannabis.
4. Insurance companies cover co-pays for patients.
5. L
hopester hopester 30 minutos hace
One can make a case for a cup and handle but its not long enough ( much to small) to be convincing to me. The same can be said for the mid-Jan to early Feb pattern that "appeared" to be a C and H but failed to follow through. There needs to be Time and Length to be recognized as a legitimate C& H t
FCEL
KIPK KIPK 31 minutos hace
Thank you...
SRMX
misterfishman misterfishman 33 minutos hace
Ihorchu everywhere he goes he is sarcastic as hell
PTTN
diggitydoodle diggitydoodle 34 minutos hace
Everyone here would be rich if everyone got a dime, every time the self proclaimed "real shareholders" said "won't be long now"...or similar so called "expert" comments over the past 3 years.
RNVA!!$$??????????
RNVA
Ranb2khz Ranb2khz 35 minutos hace
You Will Be Found – Natalie Grant (feat. Cory Asbury) (Official Lyric Video)

[yt]eHC7P4YJ9KY[/yt]

https://www.youtube.com/watch?v=eHC7P4YJ9KY






•
rmmc rmmc 35 minutos hace
You're not paying attention, there was a shot last month at a 23% profit if you are following this stock. Just wait you will see it again in December. How can something be a scam if it is a business that is running such as HIRU. IF you go by your definition of a scam then walking into a casino and p
HIRU
BIOCHEMUP BIOCHEMUP 35 minutos hace
Read this article. https://www.commercialuavnews.com/red-cat-and-palladyne-ai-partner-to-embed-artificial-intelligence-
PDYN

Su Consulta Reciente

EU
BNP
BNP Paribas
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados

BLACK FRIDAY

ADVFN

Celebrando 25 años Est 1999-2024

Ahorra hasta 60%* en Forex

1 año 40%, 2 años 40% y *3 años 60%

*Durante 3 años $1.035.00 solo $414.00